Lenz Therapeutics Stock Volatility

LENZ Stock   37.30  1.05  2.90%   
LENZ Therapeutics appears to be not too volatile, given 3 months investment horizon. LENZ Therapeutics has Sharpe Ratio of 0.18, which conveys that the firm had a 0.18% return per unit of volatility over the last 3 months. By evaluating LENZ Therapeutics' technical indicators, you can evaluate if the expected return of 0.84% is justified by implied risk. Please exercise LENZ Therapeutics' mean deviation of 3.38, and Risk Adjusted Performance of 0.1597 to check out if our risk estimates are consistent with your expectations. Key indicators related to LENZ Therapeutics' volatility include:
720 Days Market Risk
Chance Of Distress
720 Days Economic Sensitivity
LENZ Therapeutics Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of LENZ daily returns, and it is calculated using variance and standard deviation. We also use LENZ's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of LENZ Therapeutics volatility.
  
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as LENZ Therapeutics can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game. Here, they may decide to buy additional stocks of LENZ Therapeutics at lower prices. For example, an investor can purchase LENZ stock that has halved in price over a short period. This will lower your average cost per share, thereby improving your portfolio's performance when the markets normalize. Similarly, when the prices of LENZ Therapeutics' stock rises, investors can sell out and invest the proceeds in other equities with better opportunities. Investing when markets are volatile with better valuations will accord both investors and companies the opportunity to generate better long-term returns.

Moving together with LENZ Stock

  0.91BMY Bristol Myers Squibb Aggressive PushPairCorr

Moving against LENZ Stock

  0.93PEPG PepGenPairCorr
  0.89MRK Merck Company Fiscal Year End 6th of February 2025 PairCorr
  0.85JNJ Johnson Johnson Fiscal Year End 28th of January 2025 PairCorr
  0.82NKTX Nkarta Inc Buyout TrendPairCorr
  0.69FDMT 4D Molecular TherapeuticsPairCorr
  0.65MREO Mereo BioPharma GroupPairCorr
  0.62PDSB PDS Biotechnology CorpPairCorr
  0.6IVVD InvivydPairCorr
  0.44RGNX RegenxbioPairCorr

LENZ Therapeutics Market Sensitivity And Downside Risk

LENZ Therapeutics' beta coefficient measures the volatility of LENZ stock compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents LENZ stock's returns against your selected market. In other words, LENZ Therapeutics's beta of 2.53 provides an investor with an approximation of how much risk LENZ Therapeutics stock can potentially add to one of your existing portfolios. LENZ Therapeutics shows above-average downside volatility for the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure LENZ Therapeutics' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact LENZ Therapeutics' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.
3 Months Beta |Analyze LENZ Therapeutics Demand Trend
Check current 90 days LENZ Therapeutics correlation with market (Dow Jones Industrial)

LENZ Beta

    
  2.53  
LENZ standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.

Standard Deviation

    
  4.61  
It is essential to understand the difference between upside risk (as represented by LENZ Therapeutics's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of LENZ Therapeutics' daily returns or price. Since the actual investment returns on holding a position in lenz stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in LENZ Therapeutics.

LENZ Therapeutics Stock Volatility Analysis

Volatility refers to the frequency at which LENZ Therapeutics stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with LENZ Therapeutics' price changes. Investors will then calculate the volatility of LENZ Therapeutics' stock to predict their future moves. A stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of LENZ Therapeutics' volatility:

Historical Volatility

This type of stock volatility measures LENZ Therapeutics' fluctuations based on previous trends. It's commonly used to predict LENZ Therapeutics' future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.

Implied Volatility

This type of volatility provides a positive outlook on future price fluctuations for LENZ Therapeutics' current market price. This means that the stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on LENZ Therapeutics' to be redeemed at a future date.
Transformation
The output start index for this execution was zero with a total number of output elements of sixty-one. LENZ Therapeutics Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.

LENZ Therapeutics Projected Return Density Against Market

Given the investment horizon of 90 days the stock has the beta coefficient of 2.5266 . This indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, LENZ Therapeutics will likely underperform.
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to LENZ Therapeutics or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that LENZ Therapeutics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a LENZ stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
LENZ Therapeutics has an alpha of 0.6036, implying that it can generate a 0.6 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Predicted Return Density   
       Returns  
LENZ Therapeutics' volatility is measured either by using standard deviation or beta. Standard deviation will reflect the average amount of how lenz stock's price will differ from the mean after some time.To get its calculation, you should first determine the mean price during the specified period then subtract that from each price point.

What Drives a LENZ Therapeutics Price Volatility?

Several factors can influence a stock's market volatility:

Industry

Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.

Political and Economic environment

When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.

The Company's Performance

Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.

LENZ Therapeutics Stock Risk Measures

Given the investment horizon of 90 days the coefficient of variation of LENZ Therapeutics is 552.04. The daily returns are distributed with a variance of 21.25 and standard deviation of 4.61. The mean deviation of LENZ Therapeutics is currently at 3.4. For similar time horizon, the selected benchmark (Dow Jones Industrial) has volatility of 0.77
α
Alpha over Dow Jones
0.60
β
Beta against Dow Jones2.53
σ
Overall volatility
4.61
Ir
Information ratio 0.17

LENZ Therapeutics Stock Return Volatility

LENZ Therapeutics historical daily return volatility represents how much of LENZ Therapeutics stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The company inherits 4.6102% risk (volatility on return distribution) over the 90 days horizon. By contrast, Dow Jones Industrial accepts 0.7717% volatility on return distribution over the 90 days horizon.
 Performance 
       Timeline  

About LENZ Therapeutics Volatility

Volatility is a rate at which the price of LENZ Therapeutics or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of LENZ Therapeutics may increase or decrease. In other words, similar to LENZ's beta indicator, it measures the risk of LENZ Therapeutics and helps estimate the fluctuations that may happen in a short period of time. So if prices of LENZ Therapeutics fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.
Last ReportedProjected for Next Year
Market Cap101 M95.9 M
LENZ Therapeutics' stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on LENZ Stock over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much LENZ Therapeutics' price varies over time.

3 ways to utilize LENZ Therapeutics' volatility to invest better

Higher LENZ Therapeutics' stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of LENZ Therapeutics stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. LENZ Therapeutics stock volatility can provide helpful information for making investment decisions in the following ways:
  • Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of LENZ Therapeutics investment. A higher volatility means higher risk and potentially larger changes in value.
  • Identifying Opportunities: High volatility in LENZ Therapeutics' stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
  • Diversification: Understanding how the volatility of LENZ Therapeutics' stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Remember it's essential to remember that stock volatility is just one of many factors to consider when making investment decisions, and it should be used in conjunction with other fundamental and technical analysis tools.

LENZ Therapeutics Investment Opportunity

LENZ Therapeutics has a volatility of 4.61 and is 5.99 times more volatile than Dow Jones Industrial. 41 percent of all equities and portfolios are less risky than LENZ Therapeutics. You can use LENZ Therapeutics to enhance the returns of your portfolios. The stock experiences an unexpected upward trend. Watch out for market signals. Check odds of LENZ Therapeutics to be traded at 44.76 in 90 days.

Very weak diversification

The correlation between LENZ Therapeutics and DJI is 0.42 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding LENZ Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

LENZ Therapeutics Additional Risk Indicators

The analysis of LENZ Therapeutics' secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in LENZ Therapeutics' investment and either accepting that risk or mitigating it. Along with some common measures of LENZ Therapeutics stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

LENZ Therapeutics Suggested Diversification Pairs

Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against LENZ Therapeutics as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. LENZ Therapeutics' systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, LENZ Therapeutics' unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to LENZ Therapeutics.

Additional Tools for LENZ Stock Analysis

When running LENZ Therapeutics' price analysis, check to measure LENZ Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LENZ Therapeutics is operating at the current time. Most of LENZ Therapeutics' value examination focuses on studying past and present price action to predict the probability of LENZ Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LENZ Therapeutics' price. Additionally, you may evaluate how the addition of LENZ Therapeutics to your portfolios can decrease your overall portfolio volatility.